Literature DB >> 1740188

Autophagy and other vacuolar protein degradation mechanisms.

P O Seglen1, P Bohley.   

Abstract

Autophagic degradation of cytoplasm (including protein, RNA etc.) is a non-selective bulk process, as indicated by ultrastructural evidence and by the similarity in autophagic sequestration rates of various cytosolic enzymes with different half-lives. The initial autophagic sequestration step, performed by a poorly-characterized organelle called a phagophore, is subject to feedback inhibition by purines and amino acids, the effect of the latter being potentiated by insulin and antagonized by glucagon. Epinephrine and other adrenergic agonists inhibit autophagic sequestration through a prazosin-sensitive alpha 1-adrenergic mechanism. The sequestration is also inhibited by cAMP and by protein phosphorylation as indicated by the effects of cyclic nucleotide analogues, phosphodiesterase inhibitors and okadaic acid. Asparagine specifically inhibits autophagic-lysosomal fusion without having any significant effects on autophagic sequestration, on intralysosomal degradation or on the endocytic pathway. Autophaged material that accumulates in prelysosomal vacuoles in the presence of asparagine is accessible to endocytosed enzymes, revealing the existence of an amphifunctional organelle, the amphisome. Evidence from several cell types suggests that endocytosis may be coupled to autophagy to a variable extent, and that the amphisome may play a central role as a collecting station for material destined for lysosomal degradation. Protein degradation can also take place in a 'salvage compartment' closely associated with the endoplasmic reticulum (ER). In this compartment unassembled protein chains are degraded by uncharacterized proteinases, while resident proteins return to the ER and assembled secretory and membrane proteins proceed through the Golgi apparatus. In the trans-Golgi network some proteins are proteolytically processed by Ca(2+)-dependent proteinases; furthermore, this compartment sorts proteins to lysosomes, various membrane domains, endosomes or secretory vesicles/granules. Processing of both endogenous and exogenous proteins can occur in endosomes, which may play a particularly important role in antigen processing and presentation. Proteins in endosomes or secretory compartments can either be exocytosed, or channeled to lysosomes for degradation. The switch mechanisms which decide between these options are subject to bioregulation by external agents (hormones and growth factors), and may play an important role in the control of protein uptake and secretion.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1740188     DOI: 10.1007/bf01923509

Source DB:  PubMed          Journal:  Experientia        ISSN: 0014-4754


  182 in total

1.  Secretion of intact proteins and peptide fragments by lysosomal pathways of protein degradation.

Authors:  L D Isenman; J F Dice
Journal:  J Biol Chem       Date:  1989-12-25       Impact factor: 5.157

2.  Metalloendoprotease inhibitors which block the differentiation of L6 myoblasts inhibit insulin degradation by the endogenous insulin-degrading enzyme.

Authors:  C Kayalar; W T Wong
Journal:  J Biol Chem       Date:  1989-05-25       Impact factor: 5.157

3.  Amino acid and hormonal control of macromolecular turnover in perfused rat liver. Evidence for selective autophagy.

Authors:  B R Lardeux; G E Mortimore
Journal:  J Biol Chem       Date:  1987-10-25       Impact factor: 5.157

4.  6-substituted purines: a novel class of inhibitors of endogenous protein degradation in isolated rat hepatocytes.

Authors:  P B Gordon; P O Seglen
Journal:  Arch Biochem Biophys       Date:  1982-08       Impact factor: 4.013

5.  Stimulation of lysosomal enzyme secretion by growth factors.

Authors:  L Warren
Journal:  Exp Cell Res       Date:  1990-09       Impact factor: 3.905

6.  Rates of RNA degradation in isolated rat hepatocytes. Effects of amino acids and inhibitors of lysosomal function.

Authors:  S Balavoine; G Feldmann; B Lardeux
Journal:  Eur J Biochem       Date:  1990-05-20

7.  Intracellular transport, sorting, and turnover of acetylcholinesterase. Evidence for an endoglycosidase H-sensitive form in Golgi apparatus, sarcoplasmic reticulum, and clathrin-coated vesicles and its rapid degradation by a non-lysosomal mechanism.

Authors:  R L Rotundo; K Thomas; K Porter-Jordan; R J Benson; C Fernandez-Valle; R E Fine
Journal:  J Biol Chem       Date:  1989-02-25       Impact factor: 5.157

8.  Mechanism for selective secretion of a lysosomal protease by transformed mouse fibroblasts.

Authors:  J M Dong; E M Prence; G G Sahagian
Journal:  J Biol Chem       Date:  1989-05-05       Impact factor: 5.157

9.  Ammonium chloride causes reversible inhibition of low density lipoprotein receptor recycling and accelerates receptor degradation.

Authors:  K I Grant; L A Casciola; G A Coetzee; D A Sanan; W Gevers; D R van der Westhuyzen
Journal:  J Biol Chem       Date:  1990-03-05       Impact factor: 5.157

10.  Quantitative correlation between proteolysis and macro- and microautophagy in mouse hepatocytes during starvation and refeeding.

Authors:  G E Mortimore; N J Hutson; C A Surmacz
Journal:  Proc Natl Acad Sci U S A       Date:  1983-04       Impact factor: 11.205

View more
  100 in total

1.  Beclin-phosphatidylinositol 3-kinase complex functions at the trans-Golgi network.

Authors:  A Kihara; Y Kabeya; Y Ohsumi; T Yoshimori
Journal:  EMBO Rep       Date:  2001-04       Impact factor: 8.807

2.  Autophagosome-associated variant isoforms of cytosolic enzymes.

Authors:  M Fengsrud; C Raiborg; T O Berg; P E Strømhaug; T Ueno; E S Erichsen; P O Seglen
Journal:  Biochem J       Date:  2000-12-15       Impact factor: 3.857

3.  LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing.

Authors:  Y Kabeya; N Mizushima; T Ueno; A Yamamoto; T Kirisako; T Noda; E Kominami; Y Ohsumi; T Yoshimori
Journal:  EMBO J       Date:  2000-11-01       Impact factor: 11.598

Review 4.  Endolysosomal proteolysis and its regulation.

Authors:  Ché S Pillay; Edith Elliott; Clive Dennison
Journal:  Biochem J       Date:  2002-05-01       Impact factor: 3.857

Review 5.  Autophagy in the eukaryotic cell.

Authors:  Fulvio Reggiori; Daniel J Klionsky
Journal:  Eukaryot Cell       Date:  2002-02

6.  Inhibition of autophagic proteolysis by inhibitors of phosphoinositide 3-kinase can interfere with the regulation of glycogen synthesis in isolated hepatocytes.

Authors:  Peter F Dubbelhuis; Daphne A Van Sluijters; Edward F C Blommaart; Lori A Gustafson; George M Van Woerkom; Andreas W Herling; Hans-Joerg Burger; Alfred J Meijer
Journal:  Biochem J       Date:  2002-12-15       Impact factor: 3.857

7.  Role of LAMP-2 in lysosome biogenesis and autophagy.

Authors:  Eeva-Liisa Eskelinen; Anna Lena Illert; Yoshitaka Tanaka; Günter Schwarzmann; Judith Blanz; Kurt Von Figura; Paul Saftig
Journal:  Mol Biol Cell       Date:  2002-09       Impact factor: 4.138

8.  Interaction of Chlamydia trachomatis serovar L2 with the host autophagic pathway.

Authors:  Hesham M Al-Younes; Volker Brinkmann; Thomas F Meyer
Journal:  Infect Immun       Date:  2004-08       Impact factor: 3.441

Review 9.  Autophagy: a primer for the gastroenterologist/hepatologist.

Authors:  Christiane Sokollik; Michelle Ang; Nicola Jones
Journal:  Can J Gastroenterol       Date:  2011-12       Impact factor: 3.522

10.  Ubiquilin functions in autophagy and is degraded by chaperone-mediated autophagy.

Authors:  Cara Rothenberg; Deepa Srinivasan; Leann Mah; Susmita Kaushik; Corrine M Peterhoff; Janet Ugolino; Shengyun Fang; Ana Maria Cuervo; Ralph A Nixon; Mervyn J Monteiro
Journal:  Hum Mol Genet       Date:  2010-06-07       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.